{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "35867641", "DateCompleted": {"Year": "2022", "Month": "07", "Day": "26"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "28"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "07", "Day": "22"}], "ELocationID": ["e0271826", "10.1371/journal.pone.0271826"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "17", "Issue": "7", "PubDate": {"Year": "2022"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Ozone treatment effectively eliminates SARS-CoV-2 from infected face masks.", "Pagination": {"StartPage": "e0271826", "MedlinePgn": "e0271826"}, "Abstract": {"AbstractText": ["The current COVID-19 pandemic is causing profound health, economic, and social problems worldwide. The global shortage of medical and personal protective equipment (PPE) in specialized centers during the outbreak demonstrated the need for efficient methods to disinfect and recycle them in times of emergency. We have previously described that high ozone concentrations destroyed viral RNA in an inactivated SARS-CoV-2 strain within a few minutes. However, the efficient ozone dosages for active SARS-CoV-2 are still unknown. The present study aimed to evaluate the systematic effects of ozone exposure on face masks from hospitalized patients infected with SARS-CoV-2. Face masks from COVID-19 patients were collected and treated with a clinical ozone generator at high ozone concentrations in small volumes for short periods. The study focused on SARS-CoV-2 gene detection (assessed by real-time quantitative polymerase chain reaction (RT-qPCR)) and on the virus inactivation by in vitro studies. We assessed the effects of different high ozone concentrations and exposure times on decontamination efficiency. We showed that high ozone concentrations (10,000, 2,000, and 4,000 ppm) and short exposure times (10, 10, and 2 minutes, respectively), inactivated both the original strain and the B.1.1.7 strain of SARS-CoV-2 from 24 contaminated face masks from COVID-19 patients. The validation results showed that the best condition for SARS-CoV-2 inactivation was a treatment of 4,000 ppm of ozone for 2 minutes. Further studies are in progress to advance the potential applications of these findings."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto Universitario de Enfermedades Tropicales y Salud P\u00fablica de Canarias de la Universidad de La Laguna, La Laguna, Tenerife, Spain."}, {"Identifier": [], "Affiliation": "Departamento de Medicina Interna Dermatolog\u00eda y Psiquiatr\u00eda Universidad de La Laguna, La Laguna, Tenerife, Spain."}, {"Identifier": [], "Affiliation": "Red Cooperativa de Enfermedades Tropicales (RICET), Instituto de Salud Carlos III, Madrid, Spain."}, {"Identifier": [], "Affiliation": "CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain."}], "LastName": "C\u00f3rdoba-Lan\u00fas", "ForeName": "Elizabeth", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto Universitario de Enfermedades Tropicales y Salud P\u00fablica de Canarias de la Universidad de La Laguna, La Laguna, Tenerife, Spain."}, {"Identifier": [], "Affiliation": "Departamento de Medicina Interna Dermatolog\u00eda y Psiquiatr\u00eda Universidad de La Laguna, La Laguna, Tenerife, Spain."}, {"Identifier": [], "Affiliation": "Red Cooperativa de Enfermedades Tropicales (RICET), Instituto de Salud Carlos III, Madrid, Spain."}], "LastName": "Garc\u00eda-P\u00e9rez", "ForeName": "Omar", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain."}, {"Identifier": [], "Affiliation": "Research Unit Hospital Universitario Dr Negr\u00edn, Instituto de Investigaci\u00f3n Sanitaria de Canarias (IISC), Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Fundaci\u00f3n Canaria del Instituto de Investigaci\u00f3n Sanitaria de Canarias (FIISC), Las Palmas de Gran Canaria Spain."}], "LastName": "Rodr\u00edguez-Esparrag\u00f3n", "ForeName": "Francisco", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto Universitario de Enfermedades Tropicales y Salud P\u00fablica de Canarias de la Universidad de La Laguna, La Laguna, Tenerife, Spain."}, {"Identifier": [], "Affiliation": "Departamento de Obstetricia, Ginecolog\u00eda, Pediatr\u00eda, Medicina Preventiva y Salud P\u00fablica, Toxicolog\u00eda, Medicina Legal y Forense y Parasitolog\u00eda, Universidad de La Laguna La Laguna, Tenerife, Spain."}], "LastName": "Bethencourt-Estrella", "ForeName": "Carlos J", "Initials": "CJ"}, {"Identifier": ["0000-0003-3304-4176"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Unit Hospital Universitario Dr Negr\u00edn, Instituto de Investigaci\u00f3n Sanitaria de Canarias (IISC), Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Instituto Universitario de Investigaciones Biom\u00e9dicas y Sanitarias (IUIBS), BioPharm Group Universidad de Las Palmas de Gran Canaria, Spain."}], "LastName": "Torres-Mata", "ForeName": "Laura B", "Initials": "LB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemical Engineering & Materials Department, Universidad Complutense, Madrid, Spain."}], "LastName": "Blanco", "ForeName": "Angeles", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Unit Hospital Universitario Dr Negr\u00edn, Instituto de Investigaci\u00f3n Sanitaria de Canarias (IISC), Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain."}, {"Identifier": [], "Affiliation": "Li Ka Shing Knowledge Institute at the St Michael's Hospital, Toronto, Ontario, Canada."}], "LastName": "Villar", "ForeName": "Jes\u00fas", "Initials": "J"}, {"Identifier": ["0000-0002-6107-3559"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Fundaci\u00f3n Canaria del Instituto de Investigaci\u00f3n Sanitaria de Canarias (FIISC), Las Palmas de Gran Canaria Spain."}, {"Identifier": [], "Affiliation": "Internal Medicine and Infectious Diseases Department, Hospital Universitario Dr Negr\u00edn, Instituto de Investigaci\u00f3n Sanitaria de Canarias (IISC), Las Palmas de Gran Canaria, Spain."}], "LastName": "Sanz", "ForeName": "Oscar", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Fundaci\u00f3n Canaria del Instituto de Investigaci\u00f3n Sanitaria de Canarias (FIISC), Las Palmas de Gran Canaria Spain."}, {"Identifier": [], "Affiliation": "Intensive Care Unit, Hospital Universitario Dr Negr\u00edn, Instituto de Investigaci\u00f3n Sanitaria de Canarias (IISC), Las Palmas de Gran Canaria, Spain."}], "LastName": "D\u00edaz", "ForeName": "Juan J", "Initials": "JJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Unit Hospital Universitario Dr Negr\u00edn, Instituto de Investigaci\u00f3n Sanitaria de Canarias (IISC), Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Fundaci\u00f3n Canaria del Instituto de Investigaci\u00f3n Sanitaria de Canarias (FIISC), Las Palmas de Gran Canaria Spain."}, {"Identifier": [], "Affiliation": "Animal Infectious Diseases and Ictiopathology, Universitary Institute of Animal Health and Food Safety (IUSA), Universidad de Las Palmas de Gran Canaria, Arucas, Spain."}], "LastName": "Mart\u00edn-Barrasa", "ForeName": "Jos\u00e9 L", "Initials": "JL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "RETIC de Investigaci\u00f3n en Servicios de Salud en Enfermedades Cr\u00f3nicas (REDISSEC), Instituto de Salud Carlos III, Madrid, Spain."}, {"Identifier": [], "Affiliation": "Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de Salud (SESCS), Santa Cruz de Tenerife, Spain."}, {"Identifier": [], "Affiliation": "Red de Agencias de Evaluaci\u00f3n de Tecnolog\u00edas Sanitarias y Prestaciones del Sistema Nacional de Salud (RedETS), Madrid, Spain."}], "LastName": "Serrano-Aguilar", "ForeName": "Pedro", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto Universitario de Enfermedades Tropicales y Salud P\u00fablica de Canarias de la Universidad de La Laguna, La Laguna, Tenerife, Spain."}, {"Identifier": [], "Affiliation": "Red Cooperativa de Enfermedades Tropicales (RICET), Instituto de Salud Carlos III, Madrid, Spain."}, {"Identifier": [], "Affiliation": "CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain."}, {"Identifier": [], "Affiliation": "Departamento de Obstetricia, Ginecolog\u00eda, Pediatr\u00eda, Medicina Preventiva y Salud P\u00fablica, Toxicolog\u00eda, Medicina Legal y Forense y Parasitolog\u00eda, Universidad de La Laguna La Laguna, Tenerife, Spain."}], "LastName": "Pi\u00f1ero", "ForeName": "Jos\u00e9-Enrique", "Initials": "JE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain."}, {"Identifier": [], "Affiliation": "Research Unit Hospital Universitario Dr Negr\u00edn, Instituto de Investigaci\u00f3n Sanitaria de Canarias (IISC), Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Fundaci\u00f3n Canaria del Instituto de Investigaci\u00f3n Sanitaria de Canarias (FIISC), Las Palmas de Gran Canaria Spain."}, {"Identifier": [], "Affiliation": "RETIC de Investigaci\u00f3n en Servicios de Salud en Enfermedades Cr\u00f3nicas (REDISSEC), Instituto de Salud Carlos III, Madrid, Spain."}, {"Identifier": [], "Affiliation": "Chronic Pain Unit Hospital Universitario Dr Negr\u00edn Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Radiation Oncology Department, Hospital Universitario Dr Negr\u00edn Las Palmas de Gran Canaria, Spain."}], "LastName": "Clavo", "ForeName": "Bernardino", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto Universitario de Enfermedades Tropicales y Salud P\u00fablica de Canarias de la Universidad de La Laguna, La Laguna, Tenerife, Spain."}, {"Identifier": [], "Affiliation": "Red Cooperativa de Enfermedades Tropicales (RICET), Instituto de Salud Carlos III, Madrid, Spain."}, {"Identifier": [], "Affiliation": "CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain."}, {"Identifier": [], "Affiliation": "Departamento de Obstetricia, Ginecolog\u00eda, Pediatr\u00eda, Medicina Preventiva y Salud P\u00fablica, Toxicolog\u00eda, Medicina Legal y Forense y Parasitolog\u00eda, Universidad de La Laguna La Laguna, Tenerife, Spain."}], "LastName": "Lorenzo-Morales", "ForeName": "Jacob", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "SupplMeshList": ["SARS-CoV-2 variants"], "MeshHeadingList": [{"QualifierName": ["prevention & control"], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Masks"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Pandemics"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}], "CoiStatement": "The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "(ECDC), European Centre for Disease Prevention and Control. Questions and answers on COVID-19: Basic facts. [update 2022 April 25]. Available from: https://www.ecdc.europa.eu/en/covid-19/questions-answers/questions-answers-basic-facts."}, {"Citation": "Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020. Aug 25;324(8):782\u2013793. doi: 10.1001/jama.2020.12839", "ArticleIdList": ["10.1001/jama.2020.12839", "32648899"]}, {"Citation": "van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al.. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020. Apr 16;382(16):1564\u20131567. doi: 10.1056/NEJMc2004973", "ArticleIdList": ["10.1056/NEJMc2004973", "PMC7121658", "32182409"]}, {"Citation": "Chin AWH, Chu JTS, Perera MRA, Hui KPY, Yen HL, Chan MCW, et al.. Stability of SARS-CoV-2 in different environmental conditions. Lancet Microbe. 2020. May;1(1):e10. doi: 10.1016/S2666-5247(20)30003-3", "ArticleIdList": ["10.1016/S2666-5247(20)30003-3", "PMC7214863", "32835322"]}, {"Citation": "Clavo B, C\u00f3rdoba-Lan\u00fas E, Rodr\u00edguez-Esparrag\u00f3n F, Cazorla-Rivero SE, Garc\u00eda-P\u00e9rez O, Pi\u00f1ero JE, et al.. Effects of Ozone Treatment on Personal Protective Equipment Contaminated with SARS-CoV-2. Antioxidants (Basel). 2020. Dec 3;9(12):1222. doi: 10.3390/antiox9121222", "ArticleIdList": ["10.3390/antiox9121222", "PMC7761685", "33287249"]}, {"Citation": "Biryukov J, Boydston JA, Dunning RA, Yeager JJ, Wood S, Reese AL, et al.. Increasing Temperature and Relative Humidity Accelerates Inactivation of SARS-CoV-2 on Surfaces. mSphere. 2020. Jul 1;5(4):e00441\u201320. doi: 10.1128/mSphere.00441-20", "ArticleIdList": ["10.1128/mSphere.00441-20", "PMC7333574", "32611701"]}, {"Citation": "Blanco A, Ojembarrena FB, Clavo B, Negro C. Ozone potential to fight against SAR-COV-2 pandemic: facts and research needs. Environ Sci Pollut Res Int. 2021. Apr;28(13):16517\u201316531. doi: 10.1007/s11356-020-12036-9", "ArticleIdList": ["10.1007/s11356-020-12036-9", "PMC7778500", "33389580"]}, {"Citation": "Biryukov J, Boydston JA, Dunning RA, Yeager JJ, Wood S, Ferris A, et al.. SARS-CoV-2 is rapidly inactivated at high temperature. Environ Chem Lett. 2021;19(2):1773\u20131777. doi: 10.1007/s10311-021-01187-x", "ArticleIdList": ["10.1007/s10311-021-01187-x", "PMC7856623", "33551702"]}, {"Citation": "Ratnesar-Shumate S, Williams G, Green B, Krause M, Holland B, Wood S, et al.. Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces. J Infect Dis. 2020. Jun 29;222(2):214\u2013222. doi: 10.1093/infdis/jiaa274", "ArticleIdList": ["10.1093/infdis/jiaa274", "PMC7313905", "32432672"]}, {"Citation": "Kasloff SB, Leung A, Strong JE, Funk D, Cutts T. Stability of SARS-CoV-2 on critical personal protective equipment. Sci Rep. 2021. Jan 13;11(1):984. doi: 10.1038/s41598-020-80098-3", "ArticleIdList": ["10.1038/s41598-020-80098-3", "PMC7806900", "33441775"]}, {"Citation": "Fischer RJ, Morris DH, van Doremalen N, Sarchette S, Matson MJ, Bushmaker T, et al.. Effectiveness of N95 Respirator Decontamination and Reuse against SARS-CoV-2 Virus. Emerg Infect Dis. 2020. Sep;26(9):2253\u20135. doi: 10.3201/eid2609.201524", "ArticleIdList": ["10.3201/eid2609.201524", "PMC7454118", "32491983"]}, {"Citation": "Ridder MP, Paladino KD, Lowe JJ, Rupp ME. A Practical Approach to Filtering Facepiece Respirator Decontamination and Reuse: Ultraviolet Germicidal Irradiation. Curr Treat Options Infect Dis. 2021. Apr 6;13(2):1\u201312. doi: 10.1007/s40506-021-00247-8", "ArticleIdList": ["10.1007/s40506-021-00247-8", "PMC8023544", "33841050"]}, {"Citation": "Cadnum JL, Li DF, Redmond SN, John AR, Pearlmutter B, Donskey CJ. Effectiveness of Ultraviolet-C Light and a High-Level Disinfection Cabinet for Decontamination of N95 Respirators. Pathog Immun. 2020. Apr 20;5(1):52\u201367. doi: 10.20411/pai.v5i1.372", "ArticleIdList": ["10.20411/pai.v5i1.372", "PMC7192214", "32363254"]}, {"Citation": "Ranney ML, Griffeth V, Jha AK. Critical Supply Shortages\u2014The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic. N Engl J Med. 2020. Apr 30;382(18):e41. doi: 10.1056/NEJMp2006141", "ArticleIdList": ["10.1056/NEJMp2006141", "32212516"]}, {"Citation": "C\u00f3rdoba-Lan\u00fas E, Garc\u00eda-P\u00e9rez O, Cazorla-Rivero S, Rodr\u00edguez-Esparrag\u00f3n F, Pi\u00f1ero JE, Clavo B, et al.. Persistence of SARS-CoV-2 infection on personal protective equipment (PPE). BMC Infect Dis. 2021. Nov 19;21(1):1169. doi: 10.1186/s12879-021-06861-7", "ArticleIdList": ["10.1186/s12879-021-06861-7", "PMC8603335", "34798820"]}, {"Citation": "Torrey J, von Gunten U, Kohn T. Differences in Viral Disinfection Mechanisms as Revealed by Quantitative Transfection of Echovirus 11 Genomes. Appl Environ Microbiol. 2019. Jul 1;85(14):e00961\u201319. doi: 10.1128/AEM.00961-19", "ArticleIdList": ["10.1128/AEM.00961-19", "PMC6606871", "31076437"]}, {"Citation": "Murray BK, Ohmine S, Tomer DP, Jensen KJ, Johnson FB, Kirsi JJ, et al.. Virion disruption by ozone-mediated reactive oxygen species. J Virol Methods. 2008. Oct;153(1):74\u20137. doi: 10.1016/j.jviromet.2008.06.004", "ArticleIdList": ["10.1016/j.jviromet.2008.06.004", "18598719"]}, {"Citation": "Ataei-Pirkooh A, Alavi A, Kianirad M, Bagherzadeh K, Ghasempour A, Pourdakan O, et al.. Destruction mechanisms of ozone over SARS-CoV-2. Sci Rep. 2021. Sep 22;11(1):18851. doi: 10.1038/s41598-021-97860-w", "ArticleIdList": ["10.1038/s41598-021-97860-w", "PMC8458291", "34552128"]}, {"Citation": "Roy D, Wong PK, Engelbrecht RS, Chian ES. Mechanism of enteroviral inactivation by ozone. Appl Environ Microbiol. 1981. Mar;41(3):718\u201323. doi: 10.1128/aem.41.3.718-723.1981", "ArticleIdList": ["10.1128/aem.41.3.718-723.1981", "PMC243766", "6261692"]}, {"Citation": "Tizaoui C. Ozone: A Potential Oxidant for COVID-19 Virus (SARS-CoV-2), Ozone: Science & Engineering, 42:5, 378\u2013385, doi: 10.1080/01919512.2020.1795614", "ArticleIdList": ["10.1080/01919512.2020.1795614"]}, {"Citation": "Vasickova P, Pavlik I, Verani M, Carducci A. Issues Concerning Survival of Viruses on Surfaces. Food Environ Virol. 2010;2(1):24\u201334. doi: 10.1007/s12560-010-9025-6", "ArticleIdList": ["10.1007/s12560-010-9025-6"]}, {"Citation": "Bauchner H, Fontanarosa PB, Livingston EH. Conserving Supply of Personal Protective Equipment-A Call for Ideas. JAMA. 2020. May 19;323(19):1911. doi: 10.1001/jama.2020.4770", "ArticleIdList": ["10.1001/jama.2020.4770", "32196543"]}, {"Citation": "Lee J, Bong C, Lim W, Bae PK, Abafogi AT, Baek SH, et al.. Fast and Easy Disinfection of Coronavirus-Contaminated Face Masks Using Ozone Gas Produced by a Dielectric Barrier Discharge Plasma Generator. Environ Sci Technol Lett. 2021. Feb 19:acs.estlett.1c00089. doi: 10.1021/acs.estlett.1c00089", "ArticleIdList": ["10.1021/acs.estlett.1c00089"]}, {"Citation": "Dubuis ME, Dumont-Leblond N, Lalibert\u00e9 C, Veillette M, Turgeon N, Jean J, et al.. Ozone efficacy for the control of airborne viruses: Bacteriophage and norovirus models. PLoS One. 2020. Apr 10;15(4):e0231164. doi: 10.1371/journal.pone.0231164", "ArticleIdList": ["10.1371/journal.pone.0231164", "PMC7147755", "32275685"]}, {"Citation": "Yano H, Nakano R, Suzuki Y, Nakano A, Kasahara K, Hosoi H. Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment. J Hosp Infect. 2020. Dec;106(4):837\u2013838. doi: 10.1016/j.jhin.2020.10.004", "ArticleIdList": ["10.1016/j.jhin.2020.10.004", "PMC7547371", "33049366"]}, {"Citation": "Dargahi A, Jeddi F, Ghobadi H, Vosoughi M, Karami C, Sarailoo M, et al.. Evaluation of masks\u2019 internal and external surfaces used by health care workers and patients in coronavirus-2 (SARS-CoV-2) wards. Environ Res. 2021. May;196:110948. doi: 10.1016/j.envres.2021.110948", "ArticleIdList": ["10.1016/j.envres.2021.110948", "PMC7935683", "33684411"]}, {"Citation": "Yao M, Zhang L, Ma J, Zhou L. On airborne transmission and control of SARS-Cov-2. Sci Total Environ. 2020. Aug 20;731:139178. doi: 10.1016/j.scitotenv.2020.139178", "ArticleIdList": ["10.1016/j.scitotenv.2020.139178", "PMC7198171", "32388162"]}, {"Citation": "United States Department of Labor. Occupational Safety and Health Administration\u2019s (OSHA) regulations for ozone. [accessed on 2021 Oct 1]. Available from: https://www.osha.gov/laws-regs/standardinterpretations/1994-09-29-0."}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "29"}, {"Year": "2022", "Month": "7", "Day": "7"}, {"Year": "2022", "Month": "7", "Day": "22", "Hour": "13", "Minute": "32"}, {"Year": "2022", "Month": "7", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["35867641", "PMC9307172", "10.1371/journal.pone.0271826", "PONE-D-21-37794"]}}], "PubmedBookArticle": []}